Cargando…

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis

BACKGROUND: Tuberculosis is a leading cause of death worldwide, yet the determinants of death are not well understood. We sought to determine risk factors for mortality during treatment of drug-susceptible pulmonary tuberculosis under program settings. METHODS: Retrospective chart review of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nahid, Payam, Jarlsberg, Leah G, Rudoy, Irina, de Jong, Bouke C, Unger, Alon, Kawamura, L Masae, Osmond, Dennis H, Hopewell, Philip C, Daley, Charles L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022714/ https://www.ncbi.nlm.nih.gov/pubmed/21199579 http://dx.doi.org/10.1186/1471-2334-11-1

Ejemplares similares

Racial Differences in Tuberculosis Infection in United States Communities: The Coronary Artery Risk Development in Young Adults Study
por: Nahid, Payam, et al.
Publicado: (2011)

Association between Diabetes Mellitus and Tuberculosis in United States-Born and Foreign-Born Populations in San Francisco
por: Suwanpimolkul, Gompol, et al.
Publicado: (2014)

Pyrazinamide Resistance, Mycobacterium tuberculosis Lineage and Treatment Outcomes in San Francisco, California
por: Budzik, Jonathan M., et al.
Publicado: (2014)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis
por: Nahid, P., et al.
Publicado: (2018)

Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
por: Alipanah, Narges, et al.
Publicado: (2018)

Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment
por: De Groote, Mary A., et al.
Publicado: (2013)

Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection
por: Mehaffy, Carolina, et al.
Publicado: (2020)

Childhood Tuberculosis in Northern Viet Nam: A Review of 103 Cases
por: Blount, Robert J., et al.
Publicado: (2014)

Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2023)

Influence of M. tuberculosis Lineage Variability within a Clinical Trial for Pulmonary Tuberculosis
por: Nahid, Payam, et al.
Publicado: (2010)

High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Decroo, Tom, et al.
Publicado: (2020)

Use of Whole Genome Sequencing to Determine the Microevolution of Mycobacterium tuberculosis during an Outbreak
por: Kato-Maeda, Midori, et al.
Publicado: (2013)

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis
por: Coeck, Nele, et al.
Publicado: (2016)

Is susceptibility to chronic rheumatic heart disease determined in early infancy? An analysis of mortality in Britain during the 20th century
por: Phillips, D.I.W., et al.
Publicado: (2014)

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Mycobacterium africanum—Review of an Important Cause of Human Tuberculosis in West Africa
por: de Jong, Bouke C., et al.
Publicado: (2010)

The High Cost of Free Tuberculosis Services: Patient and Household Costs Associated with Tuberculosis Care in Ebonyi State, Nigeria
por: Ukwaja, Kingsley N., et al.
Publicado: (2013)

Early Detection of Tuberculosis Outbreaks among the San Francisco Homeless: Trade-Offs Between Spatial Resolution and Temporal Scale
por: Higgs, Brandon W., et al.
Publicado: (2007)

Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis
por: Imperial, Marjorie Z., et al.
Publicado: (2018)

Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control
por: Hopewell, Philip C., et al.
Publicado: (2021)

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay
por: Dewan, Puneet Kumar, et al.
Publicado: (2006)

Too little too late: Waiting for TB to come
por: Kawamura, L. Masae
Publicado: (2018)

Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
por: Sigal, G.B., et al.
Publicado: (2017)

Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California
por: Blount, Robert J., et al.
Publicado: (2017)

How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?
por: Ng, Kamela C. S., et al.
Publicado: (2019)

Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
por: Solans, Belén P, et al.
Publicado: (2023)

A Clinical Predictor Score for 30-Day Mortality among HIV-Infected Adults Hospitalized with Pneumonia in Uganda
por: Koss, Catherine A., et al.
Publicado: (2015)

Relatively low primary drug resistant tuberculosis in southwestern Ethiopia
por: Abebe, Gemeda, et al.
Publicado: (2012)

The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
por: Vernon, Andrew, et al.
Publicado: (2019)

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
por: Andries, Koen, et al.
Publicado: (2014)

Empirical Evidence for Synchrony in the Evolution of TB Cases and HIV+ Contacts among the San Francisco Homeless
por: Mohtashemi, Mojdeh, et al.
Publicado: (2010)

Immunocompromised patients with pulmonary tuberculosis; a susceptible group to intestinal parasites
por: Taghipour, Ali, et al.
Publicado: (2018)

Examining human paragonimiasis as a differential diagnosis to tuberculosis in The Gambia
por: Morter, Richard, et al.
Publicado: (2018)

Predictors of Rifampicin-Resistant Tuberculosis Mortality among HIV-Coinfected Patients in Rwanda
por: Habimana, Dominique Savio, et al.
Publicado: (2021)

Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2016)

High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals
por: Ssengooba, Willy, et al.
Publicado: (2015)

Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe
por: Metcalfe, John Z., et al.
Publicado: (2014)

Storage of Sputum in Cetylpyridinium Chloride, OMNIgene.SPUTUM, and Ethanol Is Compatible with Molecular Tuberculosis Diagnostic Testing
por: Sanoussi, C. N’Dira, et al.
Publicado: (2019)

The Effects of the Anti-Tuberculosis Campaign on the Diminution of the Mortality from Tuberculosis
por: Philip, Robert
Publicado: (1924)

Cannot write session to /tmp/vufind_sessions/sess_mgsdqfbdo999cmf6utv1or5cd7